These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

944 related items for PubMed ID: 8691638

  • 1. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y.
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [Abstract] [Full Text] [Related]

  • 2. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 3. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T, Tokuchi Y, Hayashi M, Kobayashi Y, Nishida K, Hayashi S, Ishikawa Y, Tsuchiya S, Nakagawa K, Hayashi J, Tsuchiya E.
    Cancer Res; 1999 Nov 01; 59(21):5572-7. PubMed ID: 10554037
    [Abstract] [Full Text] [Related]

  • 4. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K, Huang CL, Liu D, Masuya D, Nakashima T, Sumitomo S, Takami Y, Kinoshita M, Yokomise H.
    Clin Cancer Res; 2003 Oct 15; 9(13):4926-34. PubMed ID: 14581367
    [Abstract] [Full Text] [Related]

  • 5. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H.
    Cancer; 2002 Apr 15; 94(8):2239-47. PubMed ID: 12001123
    [Abstract] [Full Text] [Related]

  • 6. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O.
    Cancer; 1997 Sep 15; 80(6):1034-45. PubMed ID: 9305703
    [Abstract] [Full Text] [Related]

  • 7. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 8. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H, Ogura T, Yokose T, Nagai K, Nishiwaki Y, Esumi H.
    Hum Pathol; 2001 Oct 15; 32(10):1043-9. PubMed ID: 11679937
    [Abstract] [Full Text] [Related]

  • 9. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
    Laudanski J, Chyczewski L, Niklińska WE, Kretowska M, Furman M, Sawicki B, Nikliński J.
    Neoplasma; 1999 Oct 15; 46(1):25-30. PubMed ID: 10355530
    [Abstract] [Full Text] [Related]

  • 10. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K, Behera D.
    Lung Cancer; 2004 Aug 15; 45(2):181-8. PubMed ID: 15246189
    [Abstract] [Full Text] [Related]

  • 11. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
    Ohmura Y, Aoe M, Andou A, Shimizu N.
    Clin Cancer Res; 2000 Aug 15; 6(8):2980-7. PubMed ID: 10955774
    [Abstract] [Full Text] [Related]

  • 12. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
    Yaren A, Oztop I, Kargi A, Ulukus C, Onen A, Sanli A, Binicier O, Yilmaz U, Alakavuklar M.
    Int J Clin Pract; 2006 Jun 15; 60(6):675-82. PubMed ID: 16805752
    [Abstract] [Full Text] [Related]

  • 13. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, Koss M, Travis WD.
    Am J Pathol; 1996 May 15; 148(5):1531-41. PubMed ID: 8623922
    [Abstract] [Full Text] [Related]

  • 14. Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer.
    Shibata Y, Hidaka S, Tagawa Y, Nagayasu T.
    Anticancer Res; 2004 May 15; 24(3b):1925-8. PubMed ID: 15274378
    [Abstract] [Full Text] [Related]

  • 15. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
    Nakano J, Huang CL, Liu D, Ueno M, Sumitomo S, Yokomise H.
    Int J Oncol; 2005 Nov 15; 27(5):1215-21. PubMed ID: 16211215
    [Abstract] [Full Text] [Related]

  • 16. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.
    Anticancer Res; 2001 Nov 15; 21(1A):253-9. PubMed ID: 11299743
    [Abstract] [Full Text] [Related]

  • 17. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
    Zhang J, Zheng J, Fang W.
    Zhonghua Yi Xue Za Zhi; 1998 Nov 15; 78(11):846-9. PubMed ID: 11038779
    [Abstract] [Full Text] [Related]

  • 18. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M.
    Lung Cancer; 2004 Oct 01; 46(1):77-85. PubMed ID: 15364135
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 01; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.